|
|
|
|
|
|
|
Tuesday, February 12, 2008
|
|
7:15 am
|
|
|
8:15 am
|
|
|
8:30 am
|
- Learn what the IOM proposes as changes in the way healthcare marshals’ evidence and apply it to endorse the most effective clinical interventions
- Recommendations for a process to evaluate and report evidence on clinical effectiveness
- Hear the IOM’s suggested organizational framework for using evidence reports to develop recommendations on appropriate applications for specific populations
|
|
|
|
|
9:30 am
|
|
|
10:00 am
|
|
|
10:30 am
|
- Realizing the appropriateness of tools and concepts in the development of evidence based guidelines
- How to go beyond clinical guidelines to discussing both cost and quality
- How these concepts and tools are applied when examining the activities of an advisory committee on immunization policy
|
|
|
|
|
11:00 am
|
- Identifying how the timely use of health technology assessment information is fundamental to evidence based medicine
- Why evidence-informed decision making health care is becoming the norm rather than the exception all around the world
- Exploring recent developments of evidence based medicine in Canada, UK, Australia and other countries
- Discussing future trends of evidence based medicine in other countries
|
|
Kalipso Chalkidou, PhD
Associate Director, Research and Development
National Institute for Health and Clinical Excellence (NICE)
|
|
|
Tammy Clifford, PhD
Acting Vice-President
Canadian Agency for Drugs and Technologies in Health (CADTH)
|
|
|
|
12:15 pm
|
- What value does the current US health care system provide?
- How the principles and practice of evidence based medicine can increase value in the US healthcare system
- Determining the structural implications for obtaining full value from evidence based medicine
- Defining Evidence Based Plan Design and Value Based Benefits
- Exploring the need for a Center of Comparative Clinical Effectiveness
|
|
|
|
|
1:30 pm
|
|
|
|
|
|
|
|
Printer Friendly
Email A Colleague
Bookmark Page
